BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 1343705)

  • 21. Stimulation of T-helper cell gamma interferon and immunoglobulin G responses specific for Babesia bovis rhoptry-associated protein 1 (RAP-1) or a RAP-1 protein lacking the carboxy-terminal repeat region is insufficient to provide protective immunity against virulent B. bovis challenge.
    Norimine J; Mosqueda J; Suarez C; Palmer GH; McElwain TF; Mbassa G; Brown WC
    Infect Immun; 2003 Sep; 71(9):5021-32. PubMed ID: 12933845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bovine babesiosis: Cattle protected in the field with a frozen vaccine containing Babesia bovis and Babesia bigemina cultured in vitro with a serum-free medium.
    Rojas-Martínez C; Rodríguez-Vivas RI; Millán JVF; Bautista-Garfias CR; Castañeda-Arriola RO; Lira-Amaya JJ; Urióstegui PV; Carrasco JJO; Martínez JAÁ
    Parasitol Int; 2018 Apr; 67(2):190-195. PubMed ID: 29155165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Babesia bovis RON2 contains conserved B-cell epitopes that induce an invasion-blocking humoral immune response in immunized cattle.
    Hidalgo-Ruiz M; Suarez CE; Mercado-Uriostegui MA; Hernandez-Ortiz R; Ramos JA; Galindo-Velasco E; León-Ávila G; Hernández JM; Mosqueda J
    Parasit Vectors; 2018 Nov; 11(1):575. PubMed ID: 30390674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The development of a recombinant Babesia vaccine.
    Wright IG; Casu R; Commins MA; Dalrymple BP; Gale KR; Goodger BV; Riddles PW; Waltisbuhl DJ; Abetz I; Berrie DA
    Vet Parasitol; 1992 Sep; 44(1-2):3-13. PubMed ID: 1441189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune control of Babesia bovis infection.
    Brown WC; Norimine J; Knowles DP; Goff WL
    Vet Parasitol; 2006 May; 138(1-2):75-87. PubMed ID: 16510249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of candidate vaccine antigens of bovine hemoparasites Theileria parva and Babesia bovis by use of helper T cell clones.
    Brown WC; Zhao S; Logan KS; Grab DJ; Rice-Ficht AC
    Vet Parasitol; 1995 Mar; 57(1-3):189-203. PubMed ID: 7597783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential for recombinant Babesia bovis antigens to protect against a highly virulent isolate.
    Hope M; Riding G; Menzies M; Colditz I; Reverter A; Willadsen P
    Parasite Immunol; 2005 Dec; 27(12):439-45. PubMed ID: 16255742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Control of tick infestations and pathogen prevalence in cattle and sheep farms vaccinated with the recombinant Subolesin-Major Surface Protein 1a chimeric antigen.
    Torina A; Moreno-Cid JA; Blanda V; Fernández de Mera IG; de la Lastra JM; Scimeca S; Blanda M; Scariano ME; Briganò S; Disclafani R; Piazza A; Vicente J; Gortázar C; Caracappa S; Lelli RC; de la Fuente J
    Parasit Vectors; 2014 Jan; 7():10. PubMed ID: 24398155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Field studies and cost-effectiveness analysis of vaccination with Gavac against the cattle tick Boophilus microplus.
    de la Fuente J; Rodríguez M; Redondo M; Montero C; García-García JC; Méndez L; Serrano E; Valdés M; Enriquez A; Canales M; Ramos E; Boué O; Machado H; Lleonart R; de Armas CA; Rey S; Rodríguez JL; Artiles M; García L
    Vaccine; 1998 Feb; 16(4):366-73. PubMed ID: 9607057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccination with proteins involved in tick-pathogen interactions reduces vector infestations and pathogen infection.
    Merino O; Antunes S; Mosqueda J; Moreno-Cid JA; Pérez de la Lastra JM; Rosario-Cruz R; Rodríguez S; Domingos A; de la Fuente J
    Vaccine; 2013 Dec; 31(49):5889-96. PubMed ID: 24084474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced incidence of Babesia bigemina infection in cattle immunized against the cattle tick, Boophilus microplus.
    Jittapalapong S; Jansawan W; Barriga OO; Stich RW
    Ann N Y Acad Sci; 2004 Oct; 1026():312-8. PubMed ID: 15604511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccine efficacy of recombinant BmVDAC on Rhipicephalus microplus fed on Babesia bigemina-infected and uninfected cattle.
    Ortega-Sánchez R; Camacho-Nuez M; Castañeda-Ortiz EJ; Martínez-Benítez MB; Hernández-Silva DJ; Aguilar-Tipacamú G; Mosqueda J
    Vaccine; 2020 Apr; 38(19):3618-3625. PubMed ID: 31928853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transgenic Babesia bovis lacking 6-Cys sexual-stage genes as the foundation for non-transmissible live vaccines against bovine babesiosis.
    Alzan HF; Cooke BM; Suarez CE
    Ticks Tick Borne Dis; 2019 Apr; 10(3):722-728. PubMed ID: 30711475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Babesia bovis rhoptry-associated protein 1 is immunodominant for T helper cells of immune cattle and contains T-cell epitopes conserved among geographically distant B. bovis strains.
    Brown WC; McElwain TF; Ruef BJ; Suarez CE; Shkap V; Chitko-McKown CG; Tuo W; Rice-Ficht AC; Palmer GH
    Infect Immun; 1996 Aug; 64(8):3341-50. PubMed ID: 8757873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of Bm86 antigen in different strains of Boophilus microplus and effectiveness of immunization with recombinant Bm86.
    Penichet M; Rodriguez M; Castellano O; Mandado S; Rojas Y; Rubiera R; Sanchez P; Lleonart R; De La Fuente J
    Parasite Immunol; 1994 Sep; 16(9):493-500. PubMed ID: 7838598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of different heterologous prime-boost immunization strategies against Babesia bovis using viral vectored and protein-adjuvant vaccines based on a chimeric multi-antigen.
    Jaramillo Ortiz JM; Molinari MP; Gravisaco MJ; Paoletta MS; Montenegro VN; Wilkowsky SE
    Vaccine; 2016 Jul; 34(33):3913-9. PubMed ID: 27269058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospects for recombinant vaccines against Babesia bovis and related parasites.
    Brown WC; Norimine J; Goff WL; Suarez CE; McElwain TF
    Parasite Immunol; 2006 Jul; 28(7):315-27. PubMed ID: 16842268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exoantigens of an attenuated strain of Babesia bovis used as a vaccine against bovine babesiosis.
    Patarroyo JH; Prates AA; Tavares CA; Mafra CL; Vargas MI
    Vet Parasitol; 1995 Oct; 59(3-4):189-99. PubMed ID: 8533277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunization of cattle with an inactivated polyvalent vaccine against anaplasmosis and babesiosis.
    Montenegro-James S; Toro M; Leon E; Guillen AT; Lopez R; Lopez W
    Ann N Y Acad Sci; 1992 Jun; 653():112-21. PubMed ID: 1626861
    [No Abstract]   [Full Text] [Related]  

  • 40. Integrated tick and tick-borne disease control trials in crossbred dairy cattle in Malawi.
    Lawrence JA; Musisi FL; Mfitilodze MW; Tjornehoj K; Whiteland AP; Kafuwa PT; Chamambala KE
    Trop Anim Health Prod; 1996 Nov; 28(4):280-8. PubMed ID: 8983132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.